NPCE · NeuroPace Inc · Proposed Sales
$8.50
+0.53 (+6.59%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$274.58M
Shares
34.45M
Volume · Nov 17
163.06K
Avg daily vol (3M)
246.14K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-15 | MARTHA J MORRELL | Officer | 25,000 | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-30 | MARTHA J MORRELL | Officer | 78,534 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-29 | MARTHA J MORRELL | Officer | 100 | 2025-01-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-24 | MARTHA J MORRELL | Officer | 3,200 | 2025-01-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-10-28 | KCK LTD. | 10% Stockholder | 223,991 | 2024-10-25 | Goldman Sachs & Co. LLC |
| 2024-10-03 | KCK LTD. | 10% Stockholder | 190,000 | 2024-08-30 | Goldman Sachs & Co. LLC |
| 2024-03-15 | Irina Ridley | Chief Legal Officer | 3,936 | 2024-03-15 | J.P. Morgan Securities LLC |
| 2023-12-20 | Martha Morrell | Chief Medical Officer | 48,397 | 2023-12-20 | J.P. Morgan Securities LLC |
| 2023-12-06 | Martha Morrell | Affiliate | 11,005 | 2023-12-06 | J.P. Morgan Securities LLC |
| 2023-11-29 | KCK Ltd. | Shareholder | 262,836 | 2023-11-27 | Goldman Sachs & Co. LLC |
| 2023-10-02 | OrbiMed Private Investments VI, LP | Shareholder | 288,100 | 2023-10-02 | JP Morgan Chase & Co. |
Showing 1–11 of 11 filings
Key facts
CIK
1528287
CUSIP
641288105
13F (30d)
115 filings
100 filers
Visit website
Investor relations